| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/25/2000 | CA2073055C Nicotine containing stimulant unit |
| 01/25/2000 | CA2062172C Sensor processor for high-speed mail-handling machine |
| 01/25/2000 | CA2053231C Novel vitamin d analogues |
| 01/25/2000 | CA2001436C Carboxylic acid derivatives |
| 01/24/2000 | CA2277703A1 New 2-amino, 4-alkylamino pyrimidine 3-oxides and composition comprising them |
| 01/20/2000 | WO2000003248A1 Method for identifying a presenilinase inhibitor |
| 01/20/2000 | WO2000003016A1 Immunological reagent specifically interacting with the extracellular domain of the human zeta chain |
| 01/20/2000 | WO2000003015A2 Human transport protein homologs |
| 01/20/2000 | WO2000003004A2 Presenilin 2 specific ribozyme |
| 01/20/2000 | WO2000002912A2 Disintegrin homologs |
| 01/20/2000 | WO2000002897A2 Delta cleavage products and methods based thereon |
| 01/20/2000 | WO2000002892A1 Novel antibacterial compounds |
| 01/20/2000 | WO2000002881A2 Use of cysteine derivatives for preparing a medicine for treating pathologies resulting from the formation of heterotrimeric g protein |
| 01/20/2000 | WO2000002878A1 Compounds having activity at imidazoline receptors |
| 01/20/2000 | WO2000002877A2 New pharmaceutically active compounds |
| 01/20/2000 | WO2000002876A1 Improved process of synthesis of 5-methoxy- 2-[(4-methoxy- 3,5-dimethyl- 2-pyridyl)methyl]sulfinyl-1h-benzimidazole |
| 01/20/2000 | WO2000002871A1 Novel angiogenesis inhibitors |
| 01/20/2000 | WO2000002870A1 Antiviral macrocyclic compounds |
| 01/20/2000 | WO2000002865A1 Pharmaceutical agents |
| 01/20/2000 | WO2000002860A1 2-aminopyridine erivatives, their use as medicines and pharmaceutical compositions containing them |
| 01/20/2000 | WO2000002859A1 N-substituted naphthalene carboxamides as neurokinin-receptor antagonists |
| 01/20/2000 | WO2000002858A1 Aminoiminoquinone and aminoquinine alkaloid compounds as capase inhibitors |
| 01/20/2000 | WO2000002857A1 Bis-indole derivatives and their use as antiinflammatory agents |
| 01/20/2000 | WO2000002851A1 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 01/20/2000 | WO2000002850A2 Sulfonylamino carboxylic acid n-arylamides as guanylate cyclase activators |
| 01/20/2000 | WO2000002841A1 Water-soluble zinc pyruvates or their hydrates, method for the production thereof and their use |
| 01/20/2000 | WO2000002839A1 Cytokine production and tyrosine kinase inhibitors |
| 01/20/2000 | WO2000002593A2 Cleansing and treating lotion for treating comedones |
| 01/20/2000 | WO2000002592A1 Pharmaceutical composition containinig gaba analogs and an antiviral agent to treat shingles |
| 01/20/2000 | WO2000002588A1 Targeted site specific drug delivery compositions and method of use |
| 01/20/2000 | WO2000002586A1 Pharmaceutical levothyroxine preparation |
| 01/20/2000 | WO2000002581A1 Antigenic peptides derived from telomerase |
| 01/20/2000 | WO2000002573A1 Natural composition and method for the treatment of sexual dysfunction |
| 01/20/2000 | WO2000002570A1 Extracts of zanthoxylum bungeanum, pharmaceutical and cosmetic formulations containing them |
| 01/20/2000 | WO2000002569A2 Compositions for the treatment of atherosclerosis and related conditions |
| 01/20/2000 | WO2000002568A1 Coumarin and related aromatic-based polymeric prodrugs |
| 01/20/2000 | WO2000002567A1 Water miscible macrolide solutions |
| 01/20/2000 | WO2000002564A1 Prophylactic treatments of neovascularisation in macular degeneration |
| 01/20/2000 | WO2000002563A1 Steroid-containing cataplasms and process for producing the same |
| 01/20/2000 | WO2000002562A1 Compositions comprising gaba analogs and caffeine |
| 01/20/2000 | WO2000002561A1 Modulation of the phospholipase a2 pathway as a therapeutic |
| 01/20/2000 | WO2000002560A1 8-CHLORO-6,11-DIHYDRO-11-(4-PIPERIDYLIDENE)-5H-BENZO[5,6]CYCLOHEPTA[1,2-b]PYRIDINE ORAL COMPOSITIONS |
| 01/20/2000 | WO2000002558A1 Use of prenyltransferase inhibitors for preparing a medicine for treating pathologies resulting from heterotrimeric g protein membrane fixation |
| 01/20/2000 | WO2000002557A1 Use of an inhibitor of cytochrome p450 optionally combined with an antifungal agent for treating mycoses |
| 01/20/2000 | WO2000002556A1 Use of a pharmaceutical composition containing, in combination, an antagonist of the angiotensin ii at1 receptors and indomethacin for making a medicine treating chronic glomerulonephritis |
| 01/20/2000 | WO2000002555A1 Methods and compositions for the treatment of chronic lymphocytic leukemia |
| 01/20/2000 | WO2000002554A1 Vitamin e and esters thereof for use in the topical treatment of mucosal pathologies |
| 01/20/2000 | WO2000002553A1 Compositions and methods for treating and preventing bone diseases using tocotrienols |
| 01/20/2000 | WO2000002552A1 Methods involving changing the constitutive and stimulated secretions of the local reproductive system of women |
| 01/20/2000 | WO2000002551A2 Methods and compounds for treating depression |
| 01/20/2000 | WO2000002550A2 Acetylpiperazines for modulating sexual activity |
| 01/20/2000 | WO2000002549A2 Composition for and method of treating neurological disorders |
| 01/20/2000 | WO2000002548A2 Inhibitors of proteasomal activity for stimulating bone and hair growth |
| 01/20/2000 | WO2000002547A2 The treatment of renal colic with gaba analogs |
| 01/20/2000 | WO2000002546A2 Use of caba-analogues for treating insomnia |
| 01/20/2000 | WO2000002545A2 Compositions comprising gaba analogs and a decongestant to relieve sinus headache pain |
| 01/20/2000 | WO2000002544A2 Use of piperine for treating skin pigmentation disorders |
| 01/20/2000 | WO2000002543A2 Antihypersensitive combination of valsartan and calcium channel blocker |
| 01/20/2000 | WO2000002542A2 Agents with an antidepressive effect containing pramipexol and an additional antidepressant drug |
| 01/20/2000 | WO2000002541A1 Transdermal plaster containing at least one active ingredient which influences blood serum lipid levels |
| 01/20/2000 | WO2000002540A1 Plaster which contains steroids, and a method for the production and use thereof |
| 01/20/2000 | WO2000002539A1 Topical plaster with non-steroidal antirheumatic agents with an acid group |
| 01/20/2000 | WO2000002537A1 Composition containing glycerol trinitrate, method for producing said composition and use of the same |
| 01/20/2000 | WO2000002535A1 Improved stable topical ascorbic acid compositions |
| 01/20/2000 | WO2000002519A2 Utilization of derivatives of tetrahydropyridines (or 4-hydroxypiperidines)-butylazols in the preparation of a medicament for the treatment of pain |
| 01/20/2000 | WO2000002455A1 Hypericin and hypericum extract: specific t-type calcium channel blocker, and their use as t-type calcium channel targeted therapeutics |
| 01/20/2000 | WO2000002450A1 Method for treatment of fibrosis related diseases by the administration of prostacyclin derivatives |
| 01/20/2000 | WO1999059526A3 Protease inhibitors |
| 01/20/2000 | WO1999058544A9 Hybrid anthracyclines from genetically engineered streptomyces galilaeus strains |
| 01/20/2000 | WO1999058541A3 Improvements in macrolide production |
| 01/20/2000 | WO1999058518A3 Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia |
| 01/20/2000 | WO1999056773A3 Composition comprising tumor cells and extracts and method of using thereof |
| 01/20/2000 | WO1999055672A3 Antipsychotic indolyl derivatives |
| 01/20/2000 | WO1999055347A3 Treatment of papilloma virus infection using a mycobacterium |
| 01/20/2000 | WO1999052515A3 Use of organophosphoric compounds for the therapeutic and preventative treatment of infections |
| 01/20/2000 | WO1999048916A3 Hypoxia-inducible human genes, proteins, and uses thereof |
| 01/20/2000 | WO1999048858A3 Aliphatic amino carboxylic and amino phosphonic acids, amino nitriles and amino tetrazoles as cellular rescue agents |
| 01/20/2000 | WO1999047674A3 Compounds and methods for therapy and diagnosis of lung cancer |
| 01/20/2000 | WO1999045911A9 Universal reed-solomon coder-decoder |
| 01/20/2000 | WO1999045908A3 Anti-viral uses of leflunomide products |
| 01/20/2000 | WO1999044604A9 Pharmaceutical compositions containing the phospholipase inhibitor sodium [[3-(2-amino-1,2-dioxoethyl)-2-ethyl-1-phenylmethyl)-1h-indol-4-yl]oxy]acetate |
| 01/20/2000 | WO1999042092A3 Compounds and methods of use for treatment of neurogenic inflammation |
| 01/20/2000 | WO1999042091A3 Use of polycations as endosomolytic agents |
| 01/20/2000 | WO1999038964A3 Promoter regions of the mouse and human telomerase rna component genes |
| 01/20/2000 | WO1999034787A3 Fat-binding polymers |
| 01/20/2000 | WO1999026966A3 Nuclear receptor ligands and ligand binding domains |
| 01/20/2000 | WO1999021542A3 Methods for modulating macrophage proliferation using polyamine analogs |
| 01/20/2000 | DE19833786A1 New diphenyl-benzocycloheptene derivatives, are tissue-selective estrogens and antiestrogens useful e.g. for treating osteoporosis or hormone-dependent tumors or in hormone replacement therapy |
| 01/20/2000 | DE19832429A1 New imidazolylmethyl-biphenyl-sulfonylcyanamides, are sodium-dependent bicarbonate/chloride exchanger inhibitors used e.g. for treating cardiovascular disorders such as cardiac infarction |
| 01/20/2000 | DE19832428A1 New imidazolylmethyl-biphenyl-sulfonylcyanamides, are sodium-dependent bicarbonate/chloride exchanger inhibitors used e.g. for treating cardiovascular disorders such as cardiac infarction |
| 01/20/2000 | DE19832009A1 New 2,5-disubstituted benzenesulfonyl-ureas or -thioureas, used as ATP-sensitive potassium channel blockers for treating cardiovascular disorders such as arrhythmia or cardiac insufficiency |
| 01/20/2000 | DE19831985A1 New tetrafluoroethylenedioxy-benzimidazole derivatives useful as antiparasitic agents, especially for treating coccidiosis in poultry |
| 01/20/2000 | DE19831865A1 Verwendung von Schwefel-organischen Verbindungen als Mittel zur bathochromen Verschiebung der UV/Vis-Absorptionsbande von Carotinoiden Use of organosulfur compounds for effecting a bathochromic shift of the UV / Vis absorption bands of carotenoids |
| 01/20/2000 | DE19831710A1 New diacyl-hydrazine derivatives, are integrin inhibitors useful for treating e.g. thrombosis, cardiac infarction, tumors, osteoporosis, inflammation or infection |
| 01/20/2000 | CA2748996A1 Antigenic peptides derived from telomerase |
| 01/20/2000 | CA2377178A1 8-chloro-6,11-dihydro-11-(4-piperidylidene)-5h-benzo[5,6]cyclohepta[1,2]pyridine oral compositions |
| 01/20/2000 | CA2337795A1 Pharmaceutical agents |
| 01/20/2000 | CA2337753A1 Novel compositions for the treatment of atherosclerosis and related conditions |
| 01/20/2000 | CA2337261A1 Use of prenyltransferase inhibitors for preparing a medicine for treating pathologies resulting from heterotrimeric g protein membrane fixation |
| 01/20/2000 | CA2337258A1 2-aminopyridine derivatives, their use as medicines and pharmaceutical compositions containing them |